Curesee Business claims to have developed “the World’s Highest Effectiveness and Advanced Vision Treatment Software” in the company’s promotional video. “We want to pitch to connect with individuals who have a vision and establish partnerships with their company,” he added, turning to Shark Piyush.
The pitch is made in this episode of Shark Tank India by the AI-based eye treatment website CureSee.
Shark Tank India Season 2 episode from February 16 features a new deal battle between Peyush Bansal and Manita Thapar involving an eye care company. The items were well-liked by both sharks, who also want to aid the pitchers. The creators of the vision therapy company “CureSee” are the pitchers Puneet, Amit Sahni, and Jatin Kaushik.
Will the sharks offer the founder a deal?
Continue reading to learn more about the deal.
About the Brand
A sluggish eye condition known as amblyopia, which prevents individuals from seeing well even when they wear glasses, affects 30 crore people worldwide. When we go to get our eyes checked, wearing an eye patch is the recommended remedy. CureSee was therefore discovered in order to address the problem of unpleasant eye patches.
The first artificial intelligence-based vision treatment website in the world, CureSee, focuses on three issues with the human eye:
- Squint eye.
- Convergence Insufficiency.
The Indian government has recognised and aided the business. They’ve served more than 2500 patients.
They have already published one study article, and two others have been submitted for AIIMS clearance. They have played a number of games while wearing anaglyph glasses, and the outcomes are inferred from those. There are 310 active clients.
Sales and Valuation
Curesee was started in 2019. Cure see has served more than 2500 patients.
More than 200 doctors have worked associated with this business. Cure See is present in more than 40 cities. and has won 5 awards.
As a SaaS business, the hospital brings in money. For three months, the subscription costs between 12000 and 18000 rupees. 2.64 lakh rupees were sold last month.
The owner asked 40 lakhs rupees for 5% equity in the company.
Deal or no deal?
Peyush Bansal, the founder and CEO of Lenskart.com, and Namita Thapar, the executive director of Emcure Pharmaceuticals, both wanted to invest in the firm, thus the two got into a fight during the pitch. Bansal rejects each of Thapar’s ideas for the pitchers, but this ultimately causes the two of them to challenge one another about how they each want to support the business.
Namita offers 40 lakh rupees in exchange for 10% of the business.
Peyush provides two offers:
- 25 percent equity for 1 crore rupees.
- for 10% equity, 40 lakhs.
With higher valuation, Namita counters offer 40 lakhs for 7.5% equity.
Pitcher counters give Peyush 40 lakhs in exchange for 7.5 percent stock since they need him to seal the deal with them.
In exchange for another 40 lakhs and 5% equity, Namita counters.
For 10% ownership, Peyush’s counters to give 50 lakhs.
Peyush and the owner reached an agreement to trade 50 lakh rupees for 10% of the business shares.
CureSee Business has done business pitching for the goal of artificial intelligence. Outside of business, sharks have frequently struck arrangements for investments to advance science and health. After learning more about this company, you can contribute by using this platform to share any ideas you may have for investing in its growth and turning it into a source of inspiration for everyone.
Where to Find
You may also like: